Occudo Quantitative Strategies LP Buys Shares of 13,590 Maximus, Inc. (NYSE:MMS)

Occudo Quantitative Strategies LP acquired a new position in Maximus, Inc. (NYSE:MMS - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 13,590 shares of the health services provider's stock, valued at approximately $1,014,000.

Several other institutional investors have also recently made changes to their positions in MMS. Barclays PLC raised its stake in shares of Maximus by 285.1% in the third quarter. Barclays PLC now owns 170,971 shares of the health services provider's stock worth $15,927,000 after buying an additional 126,573 shares during the period. Eastern Bank bought a new position in shares of Maximus in the fourth quarter worth about $29,000. West Coast Financial LLC raised its stake in shares of Maximus by 1.7% in the fourth quarter. West Coast Financial LLC now owns 90,495 shares of the health services provider's stock worth $6,755,000 after buying an additional 1,552 shares during the period. Avanza Fonder AB bought a new position in shares of Maximus in the fourth quarter worth about $217,000. Finally, UMB Bank n.a. raised its stake in shares of Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock worth $27,000 after buying an additional 158 shares during the period. Institutional investors own 97.21% of the company's stock.

Insider Transactions at Maximus

In other news, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the transaction, the director now owns 18,097 shares in the company, valued at approximately $1,225,347.87. The trade was a 11.88% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the transaction, the insider now owns 2,512 shares of the company's stock, valued at approximately $171,167.68. This trade represents a 85.23% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.60% of the company's stock.

Maximus Price Performance

Shares of NYSE:MMS traded down $0.24 during trading on Friday, hitting $75.09. 447,250 shares of the company's stock were exchanged, compared to its average volume of 562,489. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.97. The business's 50-day simple moving average is $68.71 and its 200 day simple moving average is $72.76. The company has a market cap of $4.23 billion, a price-to-earnings ratio of 16.15 and a beta of 0.61.

Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.64. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The firm had revenue of $1.36 billion during the quarter, compared to analysts' expectations of $1.29 billion. During the same quarter last year, the business posted $1.57 earnings per share. The firm's revenue was up 1.0% on a year-over-year basis. As a group, equities analysts predict that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.60%. The ex-dividend date is Thursday, May 15th. Maximus's dividend payout ratio (DPR) is 23.86%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com cut Maximus from a "buy" rating to a "hold" rating in a research report on Thursday.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.